Abraxane® induced life-threatening toxicities with metastatic breast cancer and hepatic insufficiency
KeywordsPaclitaxel Metastatic Breast Cancer Febrile Neutropenia Taxol CYP2C8 Polymorphism
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Abraxis Oncology (2005) Abraxane (paclitaxel protein-bound particles for injectible suspension) prescribing information. Schaumburg, IL; JanuaryGoogle Scholar
- 2.Bristol-Myers Squibb Company (2005) Taxol (paclitaxel injection) prescribing information. Princeton, NJ; March 2003. Available from http://www.fda.gov/medwatch/SAFETY/2003/03MAR_PI/ Taxol_PI.pdf. Accessed July 24, 2005
- 3.Abraxis Oncology: Abraxane: Phase III Clinical Data: Abraxane vs. Taxol in Metastatic Breast Cancer (Data on file)Google Scholar
© Springer Science + Business Media, LLC 2006